Skip to main content
Figure 2 | Cancer Cell International

Figure 2

From: Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acid

Figure 2

Comparison between the two drug schedules, repeated (RS) and non-repeated (NRS). Data represent the mean ± standard deviation (SD) of three independent experiments. Error bars represent the mean ± SD. A) Dose-effect curves of Zol in breast cancer cell lines. Standard deviation never exceeded 5%. B) IC50 and LC50 values in the 2 treatment schedules. Asterisks refer to values that differ significantly (p <0.05) with respect to control values. n.r., not reached.

Back to article page